7.14
price down icon4.16%   -0.31
after-market アフターアワーズ: 7.07 -0.07 -0.98%
loading
前日終値:
$7.45
開ける:
$7.5
24時間の取引高:
708.17K
Relative Volume:
1.02
時価総額:
$138.10M
収益:
$1.54M
当期純損益:
$-84.53M
株価収益率:
-1.228
EPS:
-5.8145
ネットキャッシュフロー:
$-73.65M
1週間 パフォーマンス:
-4.55%
1か月 パフォーマンス:
-36.87%
6か月 パフォーマンス:
-14.08%
1年 パフォーマンス:
-41.19%
1日の値動き範囲:
Value
$6.97
$7.5899
1週間の範囲:
Value
$6.97
$7.98
52週間の値動き範囲:
Value
$6.325
$20.56

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile

Name
名前
Corbus Pharmaceuticals Holdings Inc
Name
セクター
Healthcare (1067)
Name
電話
617-963-0103
Name
住所
500 RIVER RIDGE DRIVE, NORWOOD, MA
Name
職員
36
Name
Twitter
@corbuspharma
Name
次回の収益日
2026-11-11
Name
最新のSEC提出書
Name
CRBP's Discussions on Twitter

Compare CRBP vs VRTX, REGN, MRNA, ARGX, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
CRBP icon
CRBP
Corbus Pharmaceuticals Holdings Inc
7.14 138.10M 1.54M -84.53M -73.65M -5.8145
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
526.19 133.37B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
788.04 81.13B 14.92B 4.42B 3.79B 41.04
MRNA icon
MRNA
Moderna Inc
198.88 79.40B 2.23B -3.19B -1.60B -8.1462
ARGX icon
ARGX
Argen X Se Adr
959.49 60.03B 4.16B 1.29B 734.26M 19.58
RVMD icon
RVMD
Revolution Medicines Inc
204.97 43.93B 742.00K -1.37B -1.07B -7.0731

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-30 再開されました B. Riley Securities Buy
2025-02-28 開始されました William Blair Outperform
2024-12-02 開始されました Piper Sandler Overweight
2024-07-30 開始されました Wedbush Outperform
2024-07-22 再開されました H.C. Wainwright Buy
2024-06-26 開始されました B. Riley Securities Buy
2024-06-03 繰り返されました Oppenheimer Outperform
2024-05-13 開始されました RBC Capital Mkts Outperform
2024-03-06 アップグレード Jefferies Hold → Buy
2020-09-08 ダウングレード BTIG Research Buy → Neutral
2020-09-08 ダウングレード Jefferies Buy → Hold
2020-09-08 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2020-09-08 ダウングレード ROTH Capital Buy → Neutral
2020-07-07 開始されました ROTH Capital Buy
2020-06-17 開始されました BTIG Research Buy
2020-03-26 開始されました Nomura Buy
2019-04-05 開始されました Jefferies Buy
2019-03-20 開始されました Oppenheimer Outperform
2019-01-11 繰り返されました Cantor Fitzgerald Overweight
2018-12-26 開始されました H.C. Wainwright Buy
2018-12-07 開始されました RBC Capital Mkts Outperform
2018-10-24 開始されました B. Riley FBR Buy
2018-01-19 開始されました Raymond James Outperform
2017-12-14 繰り返されました Cantor Fitzgerald Overweight
2017-11-08 繰り返されました Noble Financial Buy
2017-09-29 再開されました Noble Financial Buy
2017-03-30 繰り返されました Cantor Fitzgerald Overweight
2016-11-15 繰り返されました JMP Securities Mkt Outperform
2016-11-11 繰り返されました Noble Financial Buy
すべてを表示

Corbus Pharmaceuticals Holdings Inc (CRBP) 最新ニュース

pulisher
Sep 25, 2026

Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch

Sep 25, 2026
pulisher
Sep 25, 2026

Is Corbus Pharmaceuticals Holdings, Inc. (CRBP) the Cannabis Stocks Stock Everyone's About to Talk About? - Kalkine Media

Sep 25, 2026
pulisher
Sep 25, 2026

(CRBP) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Sep 25, 2026
pulisher
Sep 24, 2026

Corbus Pharmaceuticals Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Sep 24, 2026
pulisher
Sep 24, 2026

symbol__ Stock Quote Price and Forecast - CNN

Sep 24, 2026
pulisher
Sep 24, 2026

What Did CANYON Study Data Show for Corbus Pharmaceuticals (NASDAQ:CRBP)? - Kalkine Media

Sep 24, 2026
pulisher
Sep 23, 2026

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch

Sep 23, 2026
pulisher
Sep 22, 2026

Corbus Pharmaceuticals stock holds at USD 1.56 - ad-hoc-news.de

Sep 22, 2026
pulisher
Sep 22, 2026

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

Sep 22, 2026
pulisher
Sep 22, 2026

Corbus Pharmaceuticals (CRBP) Edges Higher: Shares Gain 1.18% to Close at $7.74Earnings Beat Stocks - dars.gov.et

Sep 22, 2026
pulisher
Sep 18, 2026

CRBP - Finviz

Sep 18, 2026
pulisher
Sep 17, 2026

Is CRBP a Good Cannabis Investment After Positive Obesity Study Data? - Yahoo Finance

Sep 17, 2026
pulisher
Sep 17, 2026

H.C. Wainwright Maintains Corbus Pharmaceuticals(CRBP.US) With Buy Rating, Maintains Target Price $40 - Moomoo

Sep 17, 2026
pulisher
Sep 17, 2026

Corbus Pharmaceuticals Holdings Inc. Stock Rallies 4.9%, Outperforms Peers - webull.com

Sep 17, 2026
pulisher
Sep 16, 2026

Corbus Pharmaceuticals Insider Ben Yong Offloads 2,000 Shares at $7.84 Each (NASDAQ: CRBP) - Kalkine Media

Sep 16, 2026
pulisher
Sep 16, 2026

Corbus Pharmaceuticals Holdings Inc. Stock Slides 14.4%, Underperforms Peers - webull.com

Sep 16, 2026
pulisher
Sep 15, 2026

Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Sep 15, 2026
pulisher
Sep 15, 2026

H.C. Wainwright reiterates Corbus stock rating on phase 1b data By Investing.com - Investing.com UK

Sep 15, 2026
pulisher
Sep 15, 2026

Corbus CRB-913 Delivers 5% Weight Loss in Phase 1b Obesity Study - Yahoo Finance

Sep 15, 2026
pulisher
Sep 14, 2026

Corbus reports phase 1b obesity drug trial results By Investing.com - Investing.com South Africa

Sep 14, 2026
pulisher
Sep 14, 2026

CRBP: CRB-913 achieved 5% weight loss in 12 weeks with favorable safety, supporting further clinical development - TradingView

Sep 14, 2026
pulisher
Sep 14, 2026

CRBP: CRB-913 achieved 5% weight loss in 12 weeks with mild side effects, supporting further development - TradingView

Sep 14, 2026
pulisher
Sep 14, 2026

Mizuho Securities Maintains Corbus Pharmaceuticals(CRBP.US) With Buy Rating, Maintains Target Price $33 - Moomoo

Sep 14, 2026
pulisher
Sep 14, 2026

Why is Corbus Pharmaceuticals stock surging today? By Investing.com - Investing.com Canada

Sep 14, 2026
pulisher
Sep 14, 2026

Form 8K Corbus Pharmaceuticals Holding For: 14 September By Investing.com - Investing.com India

Sep 14, 2026
pulisher
Sep 14, 2026

Corbus Pharmaceuticals stock rises on obesity drug trial data By Investing.com - Investing.com Australia

Sep 14, 2026
pulisher
Sep 14, 2026

CRBP: CRB-701 and CRB-913 show promising efficacy and safety, advancing to pivotal studies - TradingView

Sep 14, 2026
pulisher
Sep 14, 2026

Corbus Pharmaceuticals stock rises on obesity drug trial data - Investing.com

Sep 14, 2026
pulisher
Sep 14, 2026

Corbus Pharmaceuticals Announces Positive Topline Data from - GlobeNewswire

Sep 14, 2026
pulisher
Sep 14, 2026

Why Scholar Rock Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket - Benzinga

Sep 14, 2026
pulisher
Sep 11, 2026

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Sep 11, 2026
pulisher
Sep 11, 2026

Corbus Pharmaceuticals to Host Conference Call to Discuss Topline Data from CANYON-1 Clinical Trial and the Potential of CRB-913 In Obesity - Yahoo! Finance Canada

Sep 11, 2026
pulisher
Sep 10, 2026

We Think Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) Needs To Drive Business Growth Carefully - Moomoo

Sep 10, 2026
pulisher
Sep 09, 2026

Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Sep 09, 2026
pulisher
Sep 05, 2026

Corbus Pharmaceuticals Holdings stock holds steady ahead of next results - AD HOC NEWS

Sep 05, 2026
pulisher
Sep 04, 2026

How Corbus Pharmaceuticals Holdings Inc. (CRBP) Affects Rotational Strategy Timing - Stock Traders Daily

Sep 04, 2026
pulisher
Sep 02, 2026

Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch

Sep 02, 2026
pulisher
Aug 28, 2026

Corbus Pharmaceuticals Holding (CRBP) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

Aug 28, 2026
pulisher
Aug 24, 2026

Corbus (CRBP) Outlook: Finishes 4.62% Higher at $10.86 for the Current Session - vinanet.vn

Aug 24, 2026
pulisher
Aug 21, 2026

Corbus Pharmaceuticals Holdings, Inc. Revenue Breakdown – NASDAQ:CRBP - TradingView

Aug 21, 2026
pulisher
Aug 21, 2026

CRBP’s CRB-701 Phase 3 Trial Sets the Stage for a Key Oncology Catalyst - The Globe and Mail

Aug 21, 2026
pulisher
Aug 17, 2026

CRBP Q2 2026 Earnings: Wider-Than-Expected Loss of $1.81 Per Share, Yet Shares Advance 3.96%Earnings Yield Spread - vinanet.vn

Aug 17, 2026
pulisher
Aug 17, 2026

Corbus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Aug 17, 2026
pulisher
Aug 16, 2026

Corbus Pharmaceuticals (CRBP) Holds Near $10.09 as Traders Eye $10.59 ResistanceOption Breadth - vinanet.vn

Aug 16, 2026
pulisher
Aug 15, 2026

Corbus Pharmaceuticals (CRBP) Holds Near $10 as Buyers Defend Key SupportCovered Call ETF - vinanet.vn

Aug 15, 2026

Corbus Pharmaceuticals Holdings Inc (CRBP) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$117.83
price down icon 3.06%
$35.80
price down icon 0.91%
$58.21
price down icon 0.14%
$255.96
price up icon 2.55%
ONC ONC
$360.85
price up icon 0.24%
$204.97
price up icon 2.56%
大文字化:     |  ボリューム (24 時間):